Portola Pharmaceuticals Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall Street set to open lower as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
- Wall Street set to open lower as high-stakes Iran, inflation tests loom
Portola Pharma (PTLA) Prices Upsized 3.13M Common Stock Offering at $48/Share
December 4, 2015 8:01 AM ESTPortola Pharma (NASDAQ: PTLA) announced the pricing of its underwritten public offering of 3,125,000 shares of its common stock at a price to the public of $48.00 per share. In addition, the underwriters of the offering have been granted a 30-day option to purchase up to an... More
Portola Pharma (PTLA) Announces 2.6M Common Stock Offering
December 3, 2015 4:35 PM ESTPortola Pharma (NASDAQ: PTLA) announced plans to offer, subject to market and other conditions, 2,600,000 shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase up to an additional 390,000 shares of common... More
